← All indications
Otitis
Inflammation of the ear, which may be marked by pain (EARACHE), fever, HEARING DISORDERS, and VERTIGO. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS.
Subtype terms (3)
More specific conditions that are subtypes of Otitis in the MeSH hierarchy.
- Labyrinthitis
- Otitis Externa
14 drugs (12 approved, 2 experimental)
- Otitis Media
81 drugs (56 approved, 25 experimental)
Drugs by status
Approved for this indication (2)
Phase 3 trials (4)
Phase 2 trials (2)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (20)
- Abbott
- Merck
- Pfizer
- Hamilton Health Sciences Corporation
- National Institute of Allergy and Infectious Diseases (NIAID)
- University of Pittsburgh
- Baylor University
- McMaster University
- Menzies School of Health Research
- University of Melbourne
- University of Oslo
- University of Oulu
- University of British Columbia
- University of Turku
- Allegheny Health Network
- University of Barcelona
- Children's National Medical Center
- National Health and Medical Research Council, Australia
- Government of Finland
- Lumbini Medical College
Organization Involved with Phase 3 Indications (26)
- Daiichi Sankyo
- Arbor Pharmaceuticals
- Shire
- Grunenthal
- Aventis
- Sanofi
- Sanofi-Aventis
- Wyeth
- Alcon
- Exela Pharma Sciences, LLC.
- Farmoquimica S.A.
- GlaxoSmithKline
- Laboratorios Osorio de Moraes Ltda.
- Lachlan Pharma Holdings
- Otonomy, Inc.
- Par Pharmaceuticals
- Salvat
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Harvard University
- Faculdade de Medicina do ABC
- Hormozgan University of Medical Sciences
- Mayo Clinic
- Novum Pharmaceutical Research Services
- University of Oxford
- Lee's Pharmaceutical
- University of Tuebingen
Organization Involved with Phase 2 Indications (20)
- Pernix
- Otic Pharma
- IPL Therapeutics
- Pergamum AB
- DermaGen AB
- Replidyne
- Sieff Medical Center
- Tel Aviv University
- University of Minnesota
- Visions Clinical Research
- Jordan River Family Medcine
- Foothill Family Clinic
- Carolina Ear, Nose and Throat Clinic
- Kentucky Pediatric and Adult Research
- Probare i Lund AB
- University of Gothenburg
- Chonnam National University
- Synexus
- Yuhan Pharmaceutical Company
- Novus Pharma
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (17)
- TAP Pharmaceuticals
- Recordati
- ProbiSearch SL
- National Center for Complementary and Integrative Health (NCCIH)
- University of Arizona
- Duke University
- Lund University
- Utrecht University
- Uppsala University
- University of Haifa
- Emek Medical Center
- University of Ljubljana
- Technion University
- Washington University in St. Louis
- Doris Duke Charitable Foundation
- Dutch Health Care Insurance Board
- University of Antwerp